View in EDS HTML Full Text PDF Full Text

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.

Saved in:
Bibliographic Details
Title: Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.
Authors: Selmaj KW; Center for Neurology, Łódź, Poland.; Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland., Steinman L; Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, USA., Comi G; Vita-Salute San Raffaele University and Casa di Cura Igea, Milan, Italy., Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Arnold DL; NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada., Hartung HP; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia.; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Department of Neurology, Palacký University Olomouc, Olomouc, Czech Republic., Montalbán X; Department of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Havrdová EK; Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty and General University Hospital, Prague, Czech Republic., Sheffield JK; Bristol Myers Squibb, Princeton, NJ, USA., Krakovich A; Bristol Myers Squibb, Princeton, NJ, USA., Cheng CY; Bristol Myers Squibb, Princeton, NJ, USA., Riolo JV; Bristol Myers Squibb, Princeton, NJ, USA., Pachai C; Bristol Myers Squibb, Princeton, NJ, USA., Thorpe A; Bristol Myers Squibb, Princeton, NJ, USA., DeBoer E; Bristol Myers Squibb, Princeton, NJ, USA., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head Organs, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland., Cohen JA; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA., Cree BA; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Nov; Vol. 31 (13), pp. 1557-1571. Date of Electronic Publication: 2025 Nov 05.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41190505
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Selmaj+KW%22">Selmaj KW</searchLink>; Center for Neurology, Łódź, Poland.; Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.<br /><searchLink fieldCode="AU" term="%22Steinman+L%22">Steinman L</searchLink>; Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Comi+G%22">Comi G</searchLink>; Vita-Salute San Raffaele University and Casa di Cura Igea, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bar-Or+A%22">Bar-Or A</searchLink>; Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Arnold+DL%22">Arnold DL</searchLink>; NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Hartung+HP%22">Hartung HP</searchLink>; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia.; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Department of Neurology, Palacký University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Montalbán+X%22">Montalbán X</searchLink>; Department of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Havrdová+EK%22">Havrdová EK</searchLink>; Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty and General University Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sheffield+JK%22">Sheffield JK</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Krakovich+A%22">Krakovich A</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Cheng+CY%22">Cheng CY</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Riolo+JV%22">Riolo JV</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Pachai+C%22">Pachai C</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Thorpe+A%22">Thorpe A</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22DeBoer+E%22">DeBoer E</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Kappos+L%22">Kappos L</searchLink>; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head Organs, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cohen+JA%22">Cohen JA</searchLink>; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Cree+BA%22">Cree BA</searchLink>; Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2025 Nov; Vol. 31 (13), pp. 1557-1571. <i>Date of Electronic Publication: </i>2025 Nov 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41190505
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13524585251382796
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1557
    Titles:
      – TitleFull: Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Selmaj KW
      – PersonEntity:
          Name:
            NameFull: Steinman L
      – PersonEntity:
          Name:
            NameFull: Comi G
      – PersonEntity:
          Name:
            NameFull: Bar-Or A
      – PersonEntity:
          Name:
            NameFull: Arnold DL
      – PersonEntity:
          Name:
            NameFull: Hartung HP
      – PersonEntity:
          Name:
            NameFull: Montalbán X
      – PersonEntity:
          Name:
            NameFull: Havrdová EK
      – PersonEntity:
          Name:
            NameFull: Sheffield JK
      – PersonEntity:
          Name:
            NameFull: Krakovich A
      – PersonEntity:
          Name:
            NameFull: Cheng CY
      – PersonEntity:
          Name:
            NameFull: Riolo JV
      – PersonEntity:
          Name:
            NameFull: Pachai C
      – PersonEntity:
          Name:
            NameFull: Thorpe A
      – PersonEntity:
          Name:
            NameFull: DeBoer E
      – PersonEntity:
          Name:
            NameFull: Kappos L
      – PersonEntity:
          Name:
            NameFull: Cohen JA
      – PersonEntity:
          Name:
            NameFull: Cree BA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1